Trajan Group Holdings Limited (TRJ.AX)
AUD 1.0
(-3.85%)
AUD 1.0
(-3.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 | -20.35 Million AUD | -236.98% |
| 2023 | 14.86 Million AUD | 242.66% |
| 2022 | 5.14 Million AUD | 45.56% |
| 2021 | 3.45 Million AUD | 20.36% |
| 2020 | 3.26 Million AUD | -35.32% |
| 2019 | 4.45 Million AUD | 27.03% |
| 2018 | 3.15 Million AUD | 188.48% |
| 2017 | 1.09 Million AUD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q4 | 2.58 Million AUD | 0.0% |
| 2024 FY | - AUD | -38.32% |
| 2024 Q2 | 2.8 Million AUD | 122.29% |
| 2024 Q1 | 946.5 Thousand AUD | -86.95% |
| 2024 Q3 | 2.58 Million AUD | 23.08% |
| 2023 Q2 | 6.62 Million AUD | 94.94% |
| 2023 Q1 | 3.39 Million AUD | -19.96% |
| 2023 FY | - AUD | 242.66% |
| 2023 Q4 | 8.94 Million AUD | 106.75% |
| 2023 Q3 | 4.32 Million AUD | -34.63% |
| 2022 Q3 | 2.14 Million AUD | -28.66% |
| 2022 Q2 | 3 Million AUD | 81.91% |
| 2022 Q1 | 1.65 Million AUD | 273.67% |
| 2022 FY | - AUD | 45.56% |
| 2022 Q4 | 4.24 Million AUD | 97.85% |
| 2021 Q1 | 1.68 Million AUD | 379.52% |
| 2021 FY | - AUD | 20.36% |
| 2021 Q4 | -951.5 Thousand AUD | 0.0% |
| 2021 Q3 | -951.5 Thousand AUD | -131.22% |
| 2021 Q2 | 3.04 Million AUD | 80.84% |
| 2020 Q1 | 1.28 Million AUD | 0.0% |
| 2020 FY | - AUD | -35.32% |
| 2020 Q4 | 351.5 Thousand AUD | 0.0% |
| 2020 Q3 | 351.5 Thousand AUD | -78.19% |
| 2020 Q2 | 1.61 Million AUD | 25.94% |
| 2019 FY | - AUD | 27.03% |
| 2018 FY | - AUD | 188.48% |
| 2017 FY | - AUD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Austco Healthcare Limited | 8.11 Million AUD | 350.887% |
| Nanosonics Limited | 21.72 Million AUD | 193.712% |
| Osteopore Limited | -4.34 Million AUD | -368.083% |
| SDI Limited | 20.96 Million AUD | 197.123% |